New hair loss treatment DA-001 enters Large-Scale human trial
NCT ID NCT06648850
First seen Jan 11, 2026 · Last updated May 17, 2026 · Updated 24 times
Summary
This study tests whether a treatment called DA-001 can reduce hair shedding and help hair grow back in people with certain types of hair loss, including telogen effluvium and female or male pattern baldness. About 1120 adults will apply the treatment as directed and be monitored for changes in hair shedding and hair count. The goal is to see if DA-001 is safe and effective for controlling hair loss.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MALE PATTERN BALDNESS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.